Albumin Market Size, Share & Industry Analysis, By Product (Human Serum Albumin (HSA), Recombinant Albumin, and Bovine Serum Albumin (BSA)), By Application (Therapeutics, Di-agnostics, and Research), By End User (Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Albumin Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Albumin market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Albumin market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Albumin Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Albumin Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Albumin Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

CSL Limited Adopts the Strategy of Acquisition to Maintain its Leading Position
The global albumin market is highly consolidated with several key players dominating and manufacturing innovative products. CSL Limited is among the top companies having an approximate share of 30% in the global market. Owing to its acquisition of Chinese players in the market, CSL has expanded its commercial footprint across China leading to higher sales volume of the drugs. Additionally, Takeda, Grifols, S.A, and others are also investing huge sums in R&D to boost the market potential. Furthermore, the continuous investments in setting-up of fractionation units and R&D facilities are expected to drive the market growth during the forecast period. This is projected to positively impact the market as these companies are anticipated to gain higher market share during the forecast period.

LIST OF KEY COMPANIES PROFILED:

  
CSL Limitedhttps
  
Takeda Pharmaceutical Company Limited
  
Octapharma AG
  
Grifols, S.A
  
Kedrion S.p.A
  
Merck KGaA
  
Novozymes
  
Biotest AG
  
SERACARE LIFE SCIENCES
  
Other prominent players

KEY INDUSTRY DEVELOPMENTS:

March 2019 -Takeda Pharmaceutical Company Limited received the USFDA approval for the manufacturing of HAS-based therapeutic product, FLEXBUMIN, at a new manufacturing facility in Georgia. The approval has leveraged Takedas market share and increased sales.

October 2017 -Green Cross Biotherapeutics Inc. started a state-of-the-art biomanufacturing facility in Montreal and North America. The plant features a unique plasma fractionation facility and is the only Canadian manufacturing facility of plasma-derived products mainly, intravenous immunoglobulin (IVIg) and albumin.

 

REPORT COVERAGE

The global albumin market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over recent years. It further highlights some of the growth stimulating factors and restraints, helping the reader to gain in-depth knowledge about the market.

Report Scope & Segmentation

 Segmentation

By Product

  
Human Serum Albumin
  
Recombinant Albumin
  
Bovine Serum Albumin

By Application

  
Therapeutics
  
Diagnostics
  
Research

By End User

  
Hospitals & Clinics
  
Pharmaceutical & Biotechnological Industry
  
Research Institutes

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)